ARTICLE | 6 MIN | VIEWS FROM THE FLOOR

The Expected Return of the Magnificent Seven: Revisited

April 16, 2024

This much-discussed cohort of stocks experienced significant dispersion in the first quarter. Has this led to a material change in expectations?

Introduction

In January, we discussed the longer term prospects of the Magnificent Seven1 from an expected return perspective. Our simple analysis suggested that the group was priced to generate mid-single digit total returns for shareholders over the next decade, implying neither an obvious case for outstanding forward returns nor a terribly egregious current valuation. Purely from a valuation perspective, Alphabet and Meta appeared undervalued relative to this group, Tesla was an outlier on the overvalued side, and NVIDIA boasted a reasonable valuation.

While we focused on longer term expectations, it is worth revisiting our analysis given the significant dispersion in the Magnificent Seven over the first quarter. NVIDIA was the biggest winner by far among this cohort, returning +82.5%, with Meta far behind but still up a respectable +37.2% (okay, that is way more than respectable). While NVIDIA boasted a reasonable valuation at the start of the year, below we update our view on it (spoiler alert: it is less reasonable). On the reverse, Tesla significantly underperformed the group (and the market), returning -29.3%. Tesla reported poor results in January, and terrible deliveries at the beginning of April. Apple also had a difficult quarter, returning -10.9% on concerns over China market share and iPhone growth.2 So, did the dispersion we witnessed in the first quarter materially change our views?

The expected return of the Magnificent Seven (+ Eli Lilly)3

In Table 1, we update our model of the 10-year annualised expected return (the Discount Rate), given a 10-year estimate of free cash flow growth, plus a terminal growth rate.4 On the right-hand side, we show the change from the start of the year through today. We have also added American pharmaceutical company Eli Lilly & Co, a key beneficiary of the GLP-1 weight loss medication craze, that has surpassed Tesla in market capitalisation by more than a little.

NVIDIA – the clear winner in Q1 – sees the biggest drop in expected returns over the next decade, dropping from 6.4% to 4.9% annualised. While the massive Q1 rally does not make NVIDIA an obvious sell (through the lens of this framework), the potential returns going forward have been reduced. Tesla, however, looks even less attractive than it did in January, as the expected fundamentals over the period deteriorated commensurate with the drop in the stock price. The only stock in this cohort that shows an improvement in expected return is Apple, as the drop in valuation occurred with stable fundamentals. Rank-ordering the Magnificent Seven purely from this DCF model suggests Tesla remains the most expensive based on our fundamental assumptions, while Microsoft and NVIDIA are now comfortably in the expensive half of this cohort.

Table 1: What might investors realistically expect?

Source: Man Numeric and Bloomberg, as of 9 April, 2024.

Eli Lilly also appears to have low prospective returns, as the current expected FCF/EV yield is approximately 1.2%. However, profits and cash flows are expected to grow significantly over the next few years, while capital expenditures may recede following a build out to support GLP-1 sales. Thus, it is possible that free cash flow growth could be higher than our long-term assumption of 12%. In any event, it is safe to say that the market has very high expectations here, on par or even in excess with some of the expectations surrounding AI plays.

Can the Magnificent Seven (+ Eli Lilly) generate 10% annual returns?

In Table 2, we update our model to determine what level of free cash flow growth would be required to generate 10% annualised returns over the next decade. Starting with Eli Lilly, we see that would require 28% annual free cash flow growth, which equates to a free cash flow of an estimated $83 billion in 10 years versus the $9 billion expected in the coming year. That is… aggressive? Similarly, Tesla would require 31% annual free cash growth, which is actually an increase from the requirement at the beginning of the year. To be clear, there is a low base issue here, so a material near term improvement in free cash flow could make this easier to achieve.

Table 2: What would be necessary to produce a 10% annual return?

Source: Man Numeric and Bloomberg, as of 9 April, 2024.

The most notable change in the first quarter was for NVIDIA. At the start of the year, NVIDIA required 11.8% annual free cash flow growth, which seemed plausible given the near-term trajectory in earnings and cash flow. Today, NVIDIA would require 17.7% annual free cash flow growth to generate 10% annual returns over the next decade. That is a substantial increase and NVIDIA does not suffer from a low base. Microsoft is also aggressively priced, with a 19% growth requirement, though as we noted last time, they have materially accelerated capital expenditures in the near term so if/when they reduce capex, that should provide a boost to free cash flow.

Amazon, Apple, Alphabet, and Meta sit in the range of 8.8% to 13.7% required growth, which seems plausible. Arguably Apple’s requirement of 10% growth is aggressive but is still significantly less onerous than the 12.2% required at the beginning of the year.

Conclusion

The first quarter produced outstanding equity returns globally, as well as in the Magnificent Seven. Within the Magnificent Seven, the dispersion rearranged some of the potential returns going forward, though overall we still appear to be at levels consistent with mid-single digit returns. While this is not horribly exciting from a total return perspective, it is also not an obvious shorting opportunity (at least from a total return perspective).

At the beginning of the quarter, we believed NVIDIA boasted a reasonable valuation. Today that valuation is much less reasonable. Eli Lilly (which rose 33.5% in the first quarter) and Microsoft, the largest publicly traded company in the world, also bake in significant growth expectations, which may be hard to achieve and lead to relatively muted returns. Tesla remains the least attractively valued of the group (conventionally) and is obviously pricing in an option on some of its technologies. As an auto company it would be uncontroversially egregiously valued.

Earnings seasons is almost upon us; will the Magnificent Seven continue to outperform the rest of the market? They may need to exceed current expectations for that to happen.

With contributions from Dan Taylor, Chief Investment Officer at Man Numeric.

1. Apple, Microsoft, Alphabet, Amazon, NVIDIA, Meta, and Tesla.
2. Returns from 31 December 2023 to 31 March 2024 on a share price basis in US dollars. All data sourced from Man Numeric and Bloomberg.
3. Data as of 9 April 2024. All data sourced from Man Numeric and Bloomberg.
4. As in our previous analysis in January, we apply a simplistic discounted cash flow (DCF) model to determine an expected return given an expected level of free cash flow (FCF) growth. We assume a terminal growth rate of 2%. We are also assuming that these stocks are fully equity-funded, which is not a terrible assumption, but is also not strictly true as each of these companies carries a small amount of debt.

For further clarification on the terms which appear here, please visit our Glossary page.

This information is communicated and/or distributed by the relevant Man entity identified below (collectively the "Company") subject to the following conditions and restriction in their respective jurisdictions.

Opinions expressed are those of the author and may not be shared by all personnel of Man Group plc (‘Man’). These opinions are subject to change without notice, are for information purposes only and do not constitute an offer or invitation to make an investment in any financial instrument or in any product to which the Company and/or its affiliates provides investment advisory or any other financial services. Any organisations, financial instrument or products described in this material are mentioned for reference purposes only which should not be considered a recommendation for their purchase or sale. Neither the Company nor the authors shall be liable to any person for any action taken on the basis of the information provided. Some statements contained in this material concerning goals, strategies, outlook or other non-historical matters may be forward-looking statements and are based on current indicators and expectations. These forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update or revise any forward-looking statements. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those contained in the statements. The Company and/or its affiliates may or may not have a position in any financial instrument mentioned and may or may not be actively trading in any such securities. Unless stated otherwise all information is provided by the Company. Past performance is not indicative of future results.

Unless stated otherwise this information is communicated by the relevant entity listed below.

Australia: To the extent this material is distributed in Australia it is communicated by Man Investments Australia Limited ABN 47 002 747 480 AFSL 240581, which is regulated by the Australian Securities & Investments Commission ('ASIC'). This information has been prepared without taking into account anyone’s objectives, financial situation or needs.

Austria/Germany/Liechtenstein: To the extent this material is distributed in Austria, Germany and/or Liechtenstein it is communicated by Man (Europe) AG, which is authorised and regulated by the Liechtenstein Financial Market Authority (FMA). Man (Europe) AG is registered in the Principality of Liechtenstein no. FL-0002.420.371-2. Man (Europe) AG is an associated participant in the investor compensation scheme, which is operated by the Deposit Guarantee and Investor Compensation Foundation PCC (FL-0002.039.614-1) and corresponds with EU law. Further information is available on the Foundation's website under www.eas-liechtenstein.li.

European Economic Area: Unless indicated otherwise this material is communicated in the European Economic Area by Man Asset Management (Ireland) Limited (‘MAMIL’) which is registered in Ireland under company number 250493 and has its registered office at 70 Sir John Rogerson's Quay, Grand Canal Dock, Dublin 2, Ireland. MAMIL is authorised and regulated by the Central Bank of Ireland under number C22513.

Hong Kong SAR: To the extent this material is distributed in Hong Kong SAR, this material is communicated by Man Investments (Hong Kong) Limited and has not been reviewed by the Securities and Futures Commission in Hong Kong.

Japan: To the extent this material is distributed in Japan it is communicated by Man Group Japan Limited, Financial Instruments Business Operator, Director of Kanto Local Finance Bureau (Financial instruments firms) No. 624 for the purpose of providing information on investment strategies, investment services, etc. provided by Man Group, and is not a disclosure document based on laws and regulations. This material can only be communicated only to professional investors (i.e. specific investors or institutional investors as defined under Financial Instruments Exchange Law) who may have sufficient knowledge and experience of related risks.

Switzerland: To the extent this material is made available in Switzerland the communicating entity is:

  • For Clients (as such term is defined in the Swiss Financial Services Act): Man Investments (CH) AG, Huobstrasse 3, 8808 Pfäffikon SZ, Switzerland. Man Investment (CH) AG is regulated by the Swiss Financial Market Supervisory Authority (‘FINMA’); and
  • For Financial Service Providers (as defined in Art. 3 d. of FINSA, which are not Clients): Man Investments AG, Huobstrasse 3, 8808 Pfäffikon SZ, Switzerland, which is regulated by FINMA.

United Kingdom: Unless indicated otherwise this material is communicated in the United Kingdom by Man Solutions Limited ('MSL') which is a private limited company registered in England and Wales under number 3385362. MSL is authorised and regulated by the UK Financial Conduct Authority (the 'FCA') under number 185637 and has its registered office at Riverbank House, 2 Swan Lane, London, EC4R 3AD, United Kingdom.

United States: To the extent this material is distributed in the United States, it is communicated and distributed by Man Investments, Inc. (‘Man Investments’). Man Investments is registered as a broker-dealer with the SEC and is a member of the Financial Industry Regulatory Authority (‘FINRA’). Man Investments is also a member of the Securities Investor Protection Corporation (‘SIPC’). Man Investments is a wholly owned subsidiary of Man Group plc. The registration and memberships described above in no way imply a certain level of skill or expertise or that the SEC, FINRA or the SIPC have endorsed Man Investments. Man Investments Inc, 1345 Avenue of the Americas, 21st Floor, New York, NY 10105.

This material is proprietary information and may not be reproduced or otherwise disseminated in whole or in part without prior written consent. Any data services and information available from public sources used in the creation of this material are believed to be reliable. However accuracy is not warranted or guaranteed. © Man 2025